| Pharmaceutical active ingredients: |
| Cisplatin |
| Available forms, composition and doses of Cismaplat: |
| N / A |
| Cismaplat medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01XA01 - Cisplatin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Cisget | Cisplatin | Getwell Life Sciences India |
| Cis-Gry | Cisplatin | Gry-Pharma |
| Cishexal | Cisplatin | Hexal |
| Ciskebir | Cisplatin | Aspen Laboratorio Farmaceutico |
| Cislin | Deltamethrin | Unidentified Pharmaceutical Company |
| Cis-MDP | Technetium Tc-99M Medronate Kit | CIS |
| Cismox | Amoxicillin; Carbocisteine; Lactobacillus Sporogenes | Grandix Pharmaceuticals |
| Ci-Son's | Ciprofloxacin Hydrochloride | Son's Laboratorios Quimica |
| Ci-Son's CD | Ciprofloxacin Hydrochloride; Dexamethasone; Lidocaine Hydrochloride | Son's Laboratorios Quimica |
| Cisordinol | Zuclopenthixol Hydrochloride | Lundbeck; Silesia Laboratorios; Solvay |